Goldman Sachs Downgrades U.S. Large Cap Biotech Shares To Neutral
More News related to BBH
- Barclays Gets Bullish On US Biotechnology Sector (BBH)
- Goldman Sachs Downgrades U.S. Large Cap Biotech Shares To Neutral
- ETF Movers: Biotech ETFs On the Moves Following ImClone Offer
- ETF Movers 7/28: Financial Select Sector (XLF) Lower, Biotech HOLDRs (BBH) Higher, More...
- ETF Movers 7/22: Semiconductor HOLDRs (SMH) Slammed, KBW Regional Banking (KRE) Weak
More News related to Downgrades
- Massive Deficits Plague the U.S.
- The "Buy Stuff" Bell Is Ringing, Are You Listening?
- AnnTaylor (ANN) Shares Rallying as Analyst Sees Attractive Entry Point, Upgrades to Overweight
- Best of the Web 11/23: Suicides On the Rise, U.S. Debt Service Could Top $700B, Really? An Insider Trading Beauty Queen
- Bank of America's Ken Lewis Is Offering to Stay
Goldman Sachs Downgrades U.S. Large Cap Biotech Shares To Neutral.
Related ETF: Biotech HOLDRs (NYSE: BBH).
Related Categories
DowngradesStocks Mentioned
+0.99Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
